Radical Prostatectomy and Pelvic Lymph Node Dissection in Kaiser Permanente Southern California: 15-Year Experience
Author(s) -
Pooya Banapour,
Andrew Schumacher,
Jane C. Lin,
David S. Finley
Publication year - 2019
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/17-233
Subject(s) - medicine , prostatectomy , dissection (medical) , lymph node , prostate cancer , androgen deprivation therapy , biochemical recurrence , prostate specific antigen , urology , logistic regression , univariate analysis , retrospective cohort study , odds ratio , proportional hazards model , stage (stratigraphy) , multivariate analysis , surgery , cancer , paleontology , biology
Radical prostatectomy (RP) with pelvic lymph node dissection (PLND) is the standard treatment of high-risk prostate cancer. High-risk patients and those with lymph node metastasis (LNM) require further treatment. We review outcomes of RP+PLND in Kaiser Permanente Southern California (KPSC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom